SlideShare a Scribd company logo
-M.Sathish Kumar
Unit I
Age of both the partners Duration of infertility
Prior treatment Failure Cause of Infertility
Factors affecting
the Management
of Infertility
INFERTILITY
Embarrassment,
Depression.
The couple try hard
to conceive, put
pressure on
themselves.
Failure to conceive
further accentuates
the embarrassment.
Increased Stress,
Frustration,
Quality of Life
affected.
 The male and female partner are evaluated together.
 Proper and accurate information is provided to the couple
about
-the act and timing of coitus,
-nature of therapy and
-the cost of therapy.
-Treatment options available.
 It is important to mention to the couple that the probability
of unexplained infertility is around 10%.
 More importantly, the
couple are motivated not
to change consultants
regularly and be compliant
to therapy. A positive
attitude is needed.
 Counselling can help in
identifying functional
causes of infertility, like
PrimaryVaginismus.
• In cases of PCOS, Lifestyle Modification, such as following a
proper diet plan and reducing weight can go a long way in
treatment of infertility.
• Weight loss helps in increasing the levels of sex hormone
binding globulin, reduces insulin and testosterone levels ( and
hence beneficial in mild hirsutism).
Causes of Female Infertility
Ovarian
Causes
Tubal
Causes
Uterine
Causes
Cervical
Causes
Vaginal and
Peritoneal
Causes
Unexplained
Infertility
Ovulatory
Disorders
Hypogonadotropic
Hypogonadal
Anovulation
↓ GnRH,↓FSH and
↓Serum estradiol
Hypothalamic
amenorrhea due to
causes like Kallmann
syndrome, Anorexia
Nervosa etc.
GnRH
Eugonadotropic
Euestrogenic
Anovulation
Normal serum
Estradiol, FSH and
LH.
PCOS
Ovulation
Induction Drugs
Hypergonadotropic
anovulation
↑FSH
Premature
Ovarian
Failure
Artificial
Reproductive
Techniques
Hyperprolactinemic
Anovulation
↑Prolactin
↓
↓GnRH
↓
↓FSH
Bromocriptine
Drugs which induce Ovulation:
1) ClomipheneCitrate
2) Gonadotrophins
-Human menopausalGonadotrophin.
-Human chorionicGonadotrophin.
-Recombinant FSH.
3)Aromatase inhibitors
-Letrozole
-Anastrozole
Drugs which facilitate Induction:
Insulin Sensitizers
-Metformin
- Pioglitazone.
Clomiphene citrate (CC).
Clomiphene is supposed to be a SERM, but
in almost all circumstances it acts purely as
an antagonist or an anti estrogen.
It is the traditional drug of choice for ovulation
induction in anovulatory women with normal
thyroid, normal serum prolactin, normal
endogenous estrogen production – WHO Class 2.
Binds with estrogen receptors present in the
body (importantly, the hypothalamus) and blocks
them.
Loss of negative feedback to Hypothalamus
leads to an increase in the GnRH production.
Increased GnRH production causes an increase in
FSH and LH release from the Anterior Pituitary.
FSH and LH act on the ovary and stimulate
ovulation.
Clomiphene Citrate
Negative
Feedback
Inhibited
 Clomiphene is effective in the treatment of short
luteal phase.
 It is also useful empirically in association with IUI.
 It is of no use in hypogonadotropic hypogonadism.
A shortened luteal phase could be due to a defect in FSH –
as Corpus Luteum is derived from the Graafian Follicle,
The growth of which depends on FSH.
• BBT – Basal Body temperature
• OPK – Ovulation Prediction Kits (Measure urinary LH).
The dose is usually started at
the 2nd day of the cycle.
Mismatch between the rates of
ovulation and rates of pregnancy.
WHY?
 Endocervix :
Due to anti estrogenic action, the
cervical mucus becomes thinner and become
less favourable for sperm survival.
 Endometrium :
Again due to anti estrogenic action,
the endometrial growth is impaired. It may
affect ovum implantation.
Due to anti estrogenic action on
the genital tract. .
Side effects:
 Transient hot flushes-
vasomotor symptoms that occur
as a result of the drug mimicking
an estrogen deficient state.
 Other side effects –
headache, nausea,Visual
disturbances like scotoma.
Risks of ClomipheneCitrate induced
ovulation:
Multiple pregnancy .
Ovarian Hyperstimulation
Syndrome.
 It describes women who do not ovulate in response to clomiphene
and not those who fail to conceive despite ovulation.
 CC with Glucocorticoids:
Either prednisone (5mg daily) or dexamethasone (0.5 to 2 mg daily)
is used ,usually in the follicular phase. Glucocorticoids suppress
elevated androgen concentrations (DHEAS).
 CC with hCG - “Trigger shot”
Useful only in women who ovulate but where an LH surge does
not occur to trigger ovulation.
 CC with metformin- can be used Polycystic Ovarian Disease.
Metformin reduces insulin resistance.
 CC with hMG (human Menopausal Gonadotropin) - can also
be used to induce ovulation in case of resistance to
Clomiphene alone.
Not this HMG !!!!
 Used in women who do not ovulate with Clomiphene.
 hMG (human Menopausal Gonadotropin) – contains both
FSH and LH.
 Recombinant FSH – only FSH activity.
Dose – 50-75mIU/ml of FSH, given IM on day 5 of cycle.
Step up the dose based on follicular size measured in
transvaginal ultrasound.
hCG 5000 IU is administered IM to trigger ovulation.
 Perform baseline USG of ovary.
 Administer hMG ,75-150 IU/day
for 3-5 days.
 Measure estradiol. If the level of
estradiol has doubled, continue
the same HMG dosage .If not,
increase hMG by 50% for 3 days.
 Repeat step 3 until estradiol
doubles.
 Perform ovarian scan every 2-3
days until dominant follicle is 14
mm.
 The aim of the therapy is to
develop a single preovulatory
follicle.
 Androgens Estrogen.
Aromatase
Aromatase
inhibitors
Aromatase inhibitors include
Letrozole and Anastrozole.
Advantages:
1)No anti estrogenic effects on
the cervix and endometrium.
2) Monofollicular
development.
Letrozole is banned for use in
infertility due to teratogenic
effects.
 Ovarian Hyperstimulation syndrome
 MultifetalGestation.
Characterised by –
Ovarian enlargement
Ascites,
Abdominal distension
Oliguria
Management :
Conservative
Give Fluids/albumin.
Rule of ‘4’
4 punctures,
4 millimeters,
4 seconds,
40 watt current.
 GnRH can be given in a pulsatile fashion (like
the way GnRH is naturally secreted),
subcutaneously. An advantage of GnRH is
that the risk of hyperstimulation is greatly
reduced compared to hMG.
 However, GnRH is very expensive.
 In IVF, GnRH is not given in a pulsatile fashion
(in the long protocol it is given for 2 -3
weeks). It acts by desensitizing the GnRH
receptors present in the pituitary gland, to
prevent premature LH surge and thus,
premature ovulation.
 Used for short periods.
 Act by blocking the GnRH receptors in the pituitary gland.
 Prevents premature LH surge and thus premature
endogenous ovulation in patients undergoing exogenous
stimulation with FSH in preparation for IVF.
 Administered by IM or SC.
 Preparations :
 Cetrorelix
 Ganirelix
 Luteinized Unruptured Follicular Syndrome ,
micronized progesterone or hCG can be given.
 Hyperprolactinemia : Bromocriptine (Dopamine
agonist) is given , at a dose of 1.25mg at bedtime
daily for 7 days.
 Hypothyroidism: Treatment with L-Thyroxine can
help resume normal menstrual patterns and
enhance fertility in those diagnosed with
Hypothyroidism.
 . Tubal Occlusion
Proximal Tubal
Occlusion
1)Selective salpingography
2)Radiologically guided tubal
cannulation
3)Hysteroscopic cannulation
4)Microsurgery
-Resection and anastomosis
-Tubocornual anastomosis
DistalTubal
Occlusion
1) Fimbrioplasty
2) Neosalpingostomy
3) Salpingectomy and
InVitro Fertilisation
(IVF).
 For Uterine Fibroids, initial medical therapy with GnRH to shrink
the tumor size followed by Myomectomy is effective.
 For Endometrial polyps – Polypectomy is done.
 For Ashermann’s syndrome,
 Hysteroscopic Adhesiolysis is done.
 To prevent readhesions, Intra uterine
Contraceptive Device can be inserted and
Oral Contraceptive Pills can be given for 3
Cycles.
 For Uterine hypoplasia, it is best to opt
for surrogacy.
 Cervicitis
 treat the cause
 Poor cervical Mucus Production
 IUI(Intra Uterine Insemination)-effective for treatment of
unexplained infertility.
• Management of immunity against sperm:
Use of condom or a diaphragm as a barrier method
for 3 months.
Use of Immuno suppressants like dexamethasone,
cyclosporine and methotrexate.
 VAGINISMUS :
 First essential treatment is win the confidence
of the couple
 Counselling
 Fenton operation(for rigid hymen)
 DYSPAREUNIA :
 Use lubricant such as K.Y.Jelly.
 Lignocaine ointment for pain.
 Treat the local cause.
Management of
endometriosis
Symptomatic
cases
GnRH
analogues
Letrozole
RU-486
Destruction
by cautery
Excision of
cyst
adhesiolysis
Incision of
chocolate cyst
Asymptomatic
minimal
endometriosis
Observe 6-
8 months
investigate
infertility
 Peritoneal disorders like peritubal adhesions are
diagnosed laparoscopically and adhesiolysis is done.
 For unexplained infertility, low dose aspirin 75mg can
be tried out.Assisted ReproductiveTechniques are usually
required to achieve pregnancy.
TYPES OF ARTIFICIAL
INSEMINATION
 Intra Uterine
Insemination (IUI )
 Intracervical
 Pericervical & Vaginal
 Direct Intra Peritoneal
Insemination (DIPI)
STEP2
COH is done
with Clomiphene
Citrate and
follicle size is
monitored till it
reaches around
20mm.
hCG is injected to
trigger ovulation.
STEP1
STEP3
IUI is done by
introducing the
prepared
semen via an
intrauterine
catheter, 36
hours after hCG
injection.
Semen from
male partner
is collected,
washed and
stored.
 All fertility treatment procedures that involve
handling of oocytes and sperms outside the
body.
 TYPES:
 Invitro fertilization(IVF)
 Gamete intrafallopian transfer(GIFT)
 Zygote intrafallopian transfer(ZIFT)
 Intracytoplasmic sperm injection(ICSI)
 1978 -The First succesful
birth using IVF by Patrick
Steptoe and Robert
Edwards. Louise Brown was
the baby.
Louise Brown is
the lady in the
picture and not
the baby !
 Blocked/damaged fallopian tubes
 Endometriosis
 Male infertility
 Idiopathic infertility
 Immunological infertility
 Ovarian failure and diminished reserve
 Pelvic malignancy
 Process by which an
egg is fertilised outside
the body and placed
back into the body for
further development.
Controlled Ovarian Hyperstimulation with
Gonadotrophins.
Prevention of premature LH surge.
Ultrasound guided oocyte aspiration after
maturation.
Processing of Sperm.
Laboratory Fertilisation and InVitro Embryo
Culture.
Endometrial Preparation for Implantation for
the Embryo using Progesterone.
Transfer of embryos into the uterus.
 Ovarian hyperstimulation syndrome
 Multiple pregnancy
 Ectopic pregnancy
 Miscarriage
 Prematurity
 LBW babies
 Birth defects
 Results are better with
- age <35 years
- previous live birth
- previous success IVF
 poor results with
- diminished ovarian reserve
- uterine factors and smoking.
 Ovarian reserve
 Male factor
 Infectious disease
chlamydial ,HIV,HBV,HCV,
 Evaluation of uterus
HSG,Hysteroscopy,Sonohysterography.
 Intracytoplasmic
sperm injection (ICSI)
is an in vitro fertilization
procedure in which a
single sperm is injected
directly into an egg.
 Used mainly for male
infertility, it may also be
used where eggs cannot
easily be penetrated by
sperm, and occasionally
as a method of in vitro
fertilization.
 Male factor
 Oligospermia <5%
 Asthenospermia <5%
 Teratospermia <4%
 PGD
 Poor IVF/failed IVF
 In gamete intrafallopian
transfer (GIFT), eggs are
removed from the
woman, and placed in
one of the fallopian
tubes, along with the
sperm.
 This allows fertilization
to take place inside the
woman's body.
Therefore, this variation
is actually an in vivo
fertilization.
 Surrogacy is defined as carrying of pregnancy
for intended parents.
Undertaken in following conditions
- absent/diseased uterus.
- repeated pregnancy loss.
- hereditary disease.
- failed IVF.
 It refers to legal process of becoming a non-
biological parent,(the child that is not one's
biological child).
 Many prefer to have their own genetic babies
and resort to adoption when all other
measures fail.
Both had children through IVF (surrogate mothers).

More Related Content

What's hot

Retained placenta
Retained placentaRetained placenta
Retained placenta
krishnasagar1910
 
Non-contraceptive Benefits of COCP
Non-contraceptive Benefits of COCPNon-contraceptive Benefits of COCP
Non-contraceptive Benefits of COCP
Kervindran Mohanasundaram
 
Current Management of Anovulatory Infertility
Current Management of Anovulatory InfertilityCurrent Management of Anovulatory Infertility
Current Management of Anovulatory Infertility
Wale Jesudemi
 
DIENOGEST BY DR SHASHWAT JANI
DIENOGEST BY DR SHASHWAT JANIDIENOGEST BY DR SHASHWAT JANI
DIENOGEST BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
Premature labour
Premature labourPremature labour
Premature labour
Balkeej Sidhu
 
PREVENTION OF PRETERM LABOUR - EVIDENCES FOR PROGESTERONE BY DR SHASHWAT JANI
PREVENTION OF PRETERM LABOUR - EVIDENCES FOR PROGESTERONE BY DR SHASHWAT JANIPREVENTION OF PRETERM LABOUR - EVIDENCES FOR PROGESTERONE BY DR SHASHWAT JANI
PREVENTION OF PRETERM LABOUR - EVIDENCES FOR PROGESTERONE BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
Female infertility (2)
Female infertility (2)Female infertility (2)
Female infertility (2)
obgymgmcri
 
Mullerian anomalies
Mullerian anomaliesMullerian anomalies
Mullerian anomalies
drmcbansal
 
Infertility management.
Infertility management.Infertility management.
Infertility management.
Yogesh Patel
 
Medical Management of Fibroids
Medical Management of FibroidsMedical Management of Fibroids
Medical Management of Fibroids
Dr.Laxmi Agrawal Shrikhande
 
Preterm labour
Preterm labourPreterm labour
Preterm labourdrmcbansal
 
Menstrual irregularities
Menstrual irregularitiesMenstrual irregularities
Menstrual irregularities
Sandhya Kumari
 
HIV IN PREGNANCY
HIV IN PREGNANCYHIV IN PREGNANCY
HIV IN PREGNANCY
Manu Aravind
 
Abnormal labor
Abnormal laborAbnormal labor
Abnormal labor
Engidaw Ambelu
 
Premature ovarian failure
Premature ovarian failurePremature ovarian failure
Premature ovarian failureShambhu N
 
Medical management of miscarriage
Medical management of miscarriageMedical management of miscarriage
Medical management of miscarriage
Ose Okoene
 
Shoulder dystocia
Shoulder dystociaShoulder dystocia
Shoulder dystocia
Shrooti Shah
 
Thyroid diseases in pregnancy
Thyroid diseases in pregnancyThyroid diseases in pregnancy
Thyroid diseases in pregnancy
ikramdr01
 
Cervical incompetence
Cervical incompetenceCervical incompetence
Cervical incompetence
Nikita Sharma
 
Female infertility
Female infertilityFemale infertility
Female infertility
Snehlata Parashar
 

What's hot (20)

Retained placenta
Retained placentaRetained placenta
Retained placenta
 
Non-contraceptive Benefits of COCP
Non-contraceptive Benefits of COCPNon-contraceptive Benefits of COCP
Non-contraceptive Benefits of COCP
 
Current Management of Anovulatory Infertility
Current Management of Anovulatory InfertilityCurrent Management of Anovulatory Infertility
Current Management of Anovulatory Infertility
 
DIENOGEST BY DR SHASHWAT JANI
DIENOGEST BY DR SHASHWAT JANIDIENOGEST BY DR SHASHWAT JANI
DIENOGEST BY DR SHASHWAT JANI
 
Premature labour
Premature labourPremature labour
Premature labour
 
PREVENTION OF PRETERM LABOUR - EVIDENCES FOR PROGESTERONE BY DR SHASHWAT JANI
PREVENTION OF PRETERM LABOUR - EVIDENCES FOR PROGESTERONE BY DR SHASHWAT JANIPREVENTION OF PRETERM LABOUR - EVIDENCES FOR PROGESTERONE BY DR SHASHWAT JANI
PREVENTION OF PRETERM LABOUR - EVIDENCES FOR PROGESTERONE BY DR SHASHWAT JANI
 
Female infertility (2)
Female infertility (2)Female infertility (2)
Female infertility (2)
 
Mullerian anomalies
Mullerian anomaliesMullerian anomalies
Mullerian anomalies
 
Infertility management.
Infertility management.Infertility management.
Infertility management.
 
Medical Management of Fibroids
Medical Management of FibroidsMedical Management of Fibroids
Medical Management of Fibroids
 
Preterm labour
Preterm labourPreterm labour
Preterm labour
 
Menstrual irregularities
Menstrual irregularitiesMenstrual irregularities
Menstrual irregularities
 
HIV IN PREGNANCY
HIV IN PREGNANCYHIV IN PREGNANCY
HIV IN PREGNANCY
 
Abnormal labor
Abnormal laborAbnormal labor
Abnormal labor
 
Premature ovarian failure
Premature ovarian failurePremature ovarian failure
Premature ovarian failure
 
Medical management of miscarriage
Medical management of miscarriageMedical management of miscarriage
Medical management of miscarriage
 
Shoulder dystocia
Shoulder dystociaShoulder dystocia
Shoulder dystocia
 
Thyroid diseases in pregnancy
Thyroid diseases in pregnancyThyroid diseases in pregnancy
Thyroid diseases in pregnancy
 
Cervical incompetence
Cervical incompetenceCervical incompetence
Cervical incompetence
 
Female infertility
Female infertilityFemale infertility
Female infertility
 

Similar to Management of Female Infertility

Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian responseHesham Gaber
 
CLINICAL USE OF HORMONES IN BITCHES.pptx
CLINICAL USE OF HORMONES IN BITCHES.pptxCLINICAL USE OF HORMONES IN BITCHES.pptx
CLINICAL USE OF HORMONES IN BITCHES.pptx
Rameshjoshi66
 
FEMALE INFERTILITY
FEMALE INFERTILITY FEMALE INFERTILITY
FEMALE INFERTILITY
Meenakshi Vempalli
 
Oral contraceptives by shivam
Oral contraceptives by shivamOral contraceptives by shivam
Oral contraceptives by shivam
Shivam Diwaker
 
Pharmacological control of reproduction in dog and cat
Pharmacological control of reproduction in dog and catPharmacological control of reproduction in dog and cat
Pharmacological control of reproduction in dog and cat
Abdul Rehman
 
PH1.40.pptx
PH1.40.pptxPH1.40.pptx
PH1.40.pptx
Dr-Mani Bharti
 
Oral contraceptives.pptx
Oral contraceptives.pptxOral contraceptives.pptx
Oral contraceptives.pptx
ashharnomani
 
progesterone receptor.pptx
progesterone receptor.pptxprogesterone receptor.pptx
progesterone receptor.pptx
ashharnomani
 
Estrogen ,progestrone & oral contreceptive
Estrogen ,progestrone & oral contreceptiveEstrogen ,progestrone & oral contreceptive
Estrogen ,progestrone & oral contreceptive
KATHIR B.PHARM
 
Case 1 - Preconception Care #2
Case 1 - Preconception Care #2Case 1 - Preconception Care #2
Case 1 - Preconception Care #2townsellj
 
Week 1 Powerpoint
Week 1 PowerpointWeek 1 Powerpoint
Week 1 Powerpointtownsellj
 
Female infertility
Female infertilityFemale infertility
Female infertility
Dr.Pareek_06
 
Hormone therapy in postmenopausal women
Hormone therapy in postmenopausal womenHormone therapy in postmenopausal women
Hormone therapy in postmenopausal women
MayuriSimon
 
24.复件 Family Panning2008
24.复件 Family Panning200824.复件 Family Panning2008
24.复件 Family Panning2008Deep Deep
 
PCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 2 - Dr Bharati DhorepatilPCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
Bharati Dhorepatil
 
PCOS.pptx
PCOS.pptxPCOS.pptx
PCOS.pptx
ssuser7de2d21
 
Induction of ovulation
Induction of ovulationInduction of ovulation
Induction of ovulation
muhammad al hennawy
 
Fostimon pil by pharmacia1.com
Fostimon pil by pharmacia1.comFostimon pil by pharmacia1.com
Fostimon pil by pharmacia1.com
Pharmacia1 .com
 

Similar to Management of Female Infertility (20)

Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian response
 
Updated Slides
Updated SlidesUpdated Slides
Updated Slides
 
CLINICAL USE OF HORMONES IN BITCHES.pptx
CLINICAL USE OF HORMONES IN BITCHES.pptxCLINICAL USE OF HORMONES IN BITCHES.pptx
CLINICAL USE OF HORMONES IN BITCHES.pptx
 
FEMALE INFERTILITY
FEMALE INFERTILITY FEMALE INFERTILITY
FEMALE INFERTILITY
 
Oral contraceptives by shivam
Oral contraceptives by shivamOral contraceptives by shivam
Oral contraceptives by shivam
 
Pharmacological control of reproduction in dog and cat
Pharmacological control of reproduction in dog and catPharmacological control of reproduction in dog and cat
Pharmacological control of reproduction in dog and cat
 
PH1.40.pptx
PH1.40.pptxPH1.40.pptx
PH1.40.pptx
 
Oral contraceptives.pptx
Oral contraceptives.pptxOral contraceptives.pptx
Oral contraceptives.pptx
 
PROGETINS
PROGETINSPROGETINS
PROGETINS
 
progesterone receptor.pptx
progesterone receptor.pptxprogesterone receptor.pptx
progesterone receptor.pptx
 
Estrogen ,progestrone & oral contreceptive
Estrogen ,progestrone & oral contreceptiveEstrogen ,progestrone & oral contreceptive
Estrogen ,progestrone & oral contreceptive
 
Case 1 - Preconception Care #2
Case 1 - Preconception Care #2Case 1 - Preconception Care #2
Case 1 - Preconception Care #2
 
Week 1 Powerpoint
Week 1 PowerpointWeek 1 Powerpoint
Week 1 Powerpoint
 
Female infertility
Female infertilityFemale infertility
Female infertility
 
Hormone therapy in postmenopausal women
Hormone therapy in postmenopausal womenHormone therapy in postmenopausal women
Hormone therapy in postmenopausal women
 
24.复件 Family Panning2008
24.复件 Family Panning200824.复件 Family Panning2008
24.复件 Family Panning2008
 
PCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 2 - Dr Bharati DhorepatilPCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
 
PCOS.pptx
PCOS.pptxPCOS.pptx
PCOS.pptx
 
Induction of ovulation
Induction of ovulationInduction of ovulation
Induction of ovulation
 
Fostimon pil by pharmacia1.com
Fostimon pil by pharmacia1.comFostimon pil by pharmacia1.com
Fostimon pil by pharmacia1.com
 

Recently uploaded

Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 

Recently uploaded (20)

Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 

Management of Female Infertility

  • 2. Age of both the partners Duration of infertility Prior treatment Failure Cause of Infertility Factors affecting the Management of Infertility
  • 3. INFERTILITY Embarrassment, Depression. The couple try hard to conceive, put pressure on themselves. Failure to conceive further accentuates the embarrassment. Increased Stress, Frustration, Quality of Life affected.
  • 4.  The male and female partner are evaluated together.  Proper and accurate information is provided to the couple about -the act and timing of coitus, -nature of therapy and -the cost of therapy. -Treatment options available.  It is important to mention to the couple that the probability of unexplained infertility is around 10%.
  • 5.  More importantly, the couple are motivated not to change consultants regularly and be compliant to therapy. A positive attitude is needed.  Counselling can help in identifying functional causes of infertility, like PrimaryVaginismus.
  • 6. • In cases of PCOS, Lifestyle Modification, such as following a proper diet plan and reducing weight can go a long way in treatment of infertility. • Weight loss helps in increasing the levels of sex hormone binding globulin, reduces insulin and testosterone levels ( and hence beneficial in mild hirsutism).
  • 7. Causes of Female Infertility Ovarian Causes Tubal Causes Uterine Causes Cervical Causes Vaginal and Peritoneal Causes Unexplained Infertility
  • 8.
  • 9. Ovulatory Disorders Hypogonadotropic Hypogonadal Anovulation ↓ GnRH,↓FSH and ↓Serum estradiol Hypothalamic amenorrhea due to causes like Kallmann syndrome, Anorexia Nervosa etc. GnRH Eugonadotropic Euestrogenic Anovulation Normal serum Estradiol, FSH and LH. PCOS Ovulation Induction Drugs Hypergonadotropic anovulation ↑FSH Premature Ovarian Failure Artificial Reproductive Techniques Hyperprolactinemic Anovulation ↑Prolactin ↓ ↓GnRH ↓ ↓FSH Bromocriptine
  • 10. Drugs which induce Ovulation: 1) ClomipheneCitrate 2) Gonadotrophins -Human menopausalGonadotrophin. -Human chorionicGonadotrophin. -Recombinant FSH. 3)Aromatase inhibitors -Letrozole -Anastrozole Drugs which facilitate Induction: Insulin Sensitizers -Metformin - Pioglitazone.
  • 11. Clomiphene citrate (CC). Clomiphene is supposed to be a SERM, but in almost all circumstances it acts purely as an antagonist or an anti estrogen. It is the traditional drug of choice for ovulation induction in anovulatory women with normal thyroid, normal serum prolactin, normal endogenous estrogen production – WHO Class 2.
  • 12. Binds with estrogen receptors present in the body (importantly, the hypothalamus) and blocks them. Loss of negative feedback to Hypothalamus leads to an increase in the GnRH production. Increased GnRH production causes an increase in FSH and LH release from the Anterior Pituitary. FSH and LH act on the ovary and stimulate ovulation. Clomiphene Citrate
  • 14.  Clomiphene is effective in the treatment of short luteal phase.  It is also useful empirically in association with IUI.  It is of no use in hypogonadotropic hypogonadism. A shortened luteal phase could be due to a defect in FSH – as Corpus Luteum is derived from the Graafian Follicle, The growth of which depends on FSH.
  • 15. • BBT – Basal Body temperature • OPK – Ovulation Prediction Kits (Measure urinary LH). The dose is usually started at the 2nd day of the cycle.
  • 16. Mismatch between the rates of ovulation and rates of pregnancy. WHY?  Endocervix : Due to anti estrogenic action, the cervical mucus becomes thinner and become less favourable for sperm survival.  Endometrium : Again due to anti estrogenic action, the endometrial growth is impaired. It may affect ovum implantation. Due to anti estrogenic action on the genital tract. .
  • 17. Side effects:  Transient hot flushes- vasomotor symptoms that occur as a result of the drug mimicking an estrogen deficient state.  Other side effects – headache, nausea,Visual disturbances like scotoma. Risks of ClomipheneCitrate induced ovulation: Multiple pregnancy . Ovarian Hyperstimulation Syndrome.
  • 18.  It describes women who do not ovulate in response to clomiphene and not those who fail to conceive despite ovulation.  CC with Glucocorticoids: Either prednisone (5mg daily) or dexamethasone (0.5 to 2 mg daily) is used ,usually in the follicular phase. Glucocorticoids suppress elevated androgen concentrations (DHEAS).  CC with hCG - “Trigger shot” Useful only in women who ovulate but where an LH surge does not occur to trigger ovulation.
  • 19.  CC with metformin- can be used Polycystic Ovarian Disease. Metformin reduces insulin resistance.  CC with hMG (human Menopausal Gonadotropin) - can also be used to induce ovulation in case of resistance to Clomiphene alone. Not this HMG !!!!
  • 20.  Used in women who do not ovulate with Clomiphene.  hMG (human Menopausal Gonadotropin) – contains both FSH and LH.  Recombinant FSH – only FSH activity. Dose – 50-75mIU/ml of FSH, given IM on day 5 of cycle. Step up the dose based on follicular size measured in transvaginal ultrasound. hCG 5000 IU is administered IM to trigger ovulation.
  • 21.  Perform baseline USG of ovary.  Administer hMG ,75-150 IU/day for 3-5 days.  Measure estradiol. If the level of estradiol has doubled, continue the same HMG dosage .If not, increase hMG by 50% for 3 days.  Repeat step 3 until estradiol doubles.  Perform ovarian scan every 2-3 days until dominant follicle is 14 mm.  The aim of the therapy is to develop a single preovulatory follicle.
  • 22.  Androgens Estrogen. Aromatase Aromatase inhibitors Aromatase inhibitors include Letrozole and Anastrozole. Advantages: 1)No anti estrogenic effects on the cervix and endometrium. 2) Monofollicular development. Letrozole is banned for use in infertility due to teratogenic effects.
  • 23.  Ovarian Hyperstimulation syndrome  MultifetalGestation. Characterised by – Ovarian enlargement Ascites, Abdominal distension Oliguria Management : Conservative Give Fluids/albumin.
  • 24. Rule of ‘4’ 4 punctures, 4 millimeters, 4 seconds, 40 watt current.
  • 25.  GnRH can be given in a pulsatile fashion (like the way GnRH is naturally secreted), subcutaneously. An advantage of GnRH is that the risk of hyperstimulation is greatly reduced compared to hMG.  However, GnRH is very expensive.
  • 26.  In IVF, GnRH is not given in a pulsatile fashion (in the long protocol it is given for 2 -3 weeks). It acts by desensitizing the GnRH receptors present in the pituitary gland, to prevent premature LH surge and thus, premature ovulation.
  • 27.  Used for short periods.  Act by blocking the GnRH receptors in the pituitary gland.  Prevents premature LH surge and thus premature endogenous ovulation in patients undergoing exogenous stimulation with FSH in preparation for IVF.  Administered by IM or SC.  Preparations :  Cetrorelix  Ganirelix
  • 28.  Luteinized Unruptured Follicular Syndrome , micronized progesterone or hCG can be given.  Hyperprolactinemia : Bromocriptine (Dopamine agonist) is given , at a dose of 1.25mg at bedtime daily for 7 days.  Hypothyroidism: Treatment with L-Thyroxine can help resume normal menstrual patterns and enhance fertility in those diagnosed with Hypothyroidism.
  • 29.  . Tubal Occlusion Proximal Tubal Occlusion 1)Selective salpingography 2)Radiologically guided tubal cannulation 3)Hysteroscopic cannulation 4)Microsurgery -Resection and anastomosis -Tubocornual anastomosis DistalTubal Occlusion 1) Fimbrioplasty 2) Neosalpingostomy 3) Salpingectomy and InVitro Fertilisation (IVF).
  • 30.  For Uterine Fibroids, initial medical therapy with GnRH to shrink the tumor size followed by Myomectomy is effective.  For Endometrial polyps – Polypectomy is done.  For Ashermann’s syndrome,  Hysteroscopic Adhesiolysis is done.  To prevent readhesions, Intra uterine Contraceptive Device can be inserted and Oral Contraceptive Pills can be given for 3 Cycles.  For Uterine hypoplasia, it is best to opt for surrogacy.
  • 31.  Cervicitis  treat the cause  Poor cervical Mucus Production  IUI(Intra Uterine Insemination)-effective for treatment of unexplained infertility. • Management of immunity against sperm: Use of condom or a diaphragm as a barrier method for 3 months. Use of Immuno suppressants like dexamethasone, cyclosporine and methotrexate.
  • 32.  VAGINISMUS :  First essential treatment is win the confidence of the couple  Counselling  Fenton operation(for rigid hymen)  DYSPAREUNIA :  Use lubricant such as K.Y.Jelly.  Lignocaine ointment for pain.  Treat the local cause.
  • 33. Management of endometriosis Symptomatic cases GnRH analogues Letrozole RU-486 Destruction by cautery Excision of cyst adhesiolysis Incision of chocolate cyst Asymptomatic minimal endometriosis Observe 6- 8 months investigate infertility
  • 34.  Peritoneal disorders like peritubal adhesions are diagnosed laparoscopically and adhesiolysis is done.  For unexplained infertility, low dose aspirin 75mg can be tried out.Assisted ReproductiveTechniques are usually required to achieve pregnancy.
  • 35. TYPES OF ARTIFICIAL INSEMINATION  Intra Uterine Insemination (IUI )  Intracervical  Pericervical & Vaginal  Direct Intra Peritoneal Insemination (DIPI)
  • 36. STEP2 COH is done with Clomiphene Citrate and follicle size is monitored till it reaches around 20mm. hCG is injected to trigger ovulation. STEP1 STEP3 IUI is done by introducing the prepared semen via an intrauterine catheter, 36 hours after hCG injection. Semen from male partner is collected, washed and stored.
  • 37.  All fertility treatment procedures that involve handling of oocytes and sperms outside the body.  TYPES:  Invitro fertilization(IVF)  Gamete intrafallopian transfer(GIFT)  Zygote intrafallopian transfer(ZIFT)  Intracytoplasmic sperm injection(ICSI)
  • 38.  1978 -The First succesful birth using IVF by Patrick Steptoe and Robert Edwards. Louise Brown was the baby. Louise Brown is the lady in the picture and not the baby !
  • 39.  Blocked/damaged fallopian tubes  Endometriosis  Male infertility  Idiopathic infertility  Immunological infertility  Ovarian failure and diminished reserve  Pelvic malignancy
  • 40.  Process by which an egg is fertilised outside the body and placed back into the body for further development.
  • 41. Controlled Ovarian Hyperstimulation with Gonadotrophins. Prevention of premature LH surge. Ultrasound guided oocyte aspiration after maturation. Processing of Sperm. Laboratory Fertilisation and InVitro Embryo Culture. Endometrial Preparation for Implantation for the Embryo using Progesterone. Transfer of embryos into the uterus.
  • 42.
  • 43.  Ovarian hyperstimulation syndrome  Multiple pregnancy  Ectopic pregnancy  Miscarriage  Prematurity  LBW babies  Birth defects
  • 44.  Results are better with - age <35 years - previous live birth - previous success IVF  poor results with - diminished ovarian reserve - uterine factors and smoking.
  • 45.  Ovarian reserve  Male factor  Infectious disease chlamydial ,HIV,HBV,HCV,  Evaluation of uterus HSG,Hysteroscopy,Sonohysterography.
  • 46.  Intracytoplasmic sperm injection (ICSI) is an in vitro fertilization procedure in which a single sperm is injected directly into an egg.  Used mainly for male infertility, it may also be used where eggs cannot easily be penetrated by sperm, and occasionally as a method of in vitro fertilization.
  • 47.  Male factor  Oligospermia <5%  Asthenospermia <5%  Teratospermia <4%  PGD  Poor IVF/failed IVF
  • 48.  In gamete intrafallopian transfer (GIFT), eggs are removed from the woman, and placed in one of the fallopian tubes, along with the sperm.  This allows fertilization to take place inside the woman's body. Therefore, this variation is actually an in vivo fertilization.
  • 49.
  • 50.  Surrogacy is defined as carrying of pregnancy for intended parents. Undertaken in following conditions - absent/diseased uterus. - repeated pregnancy loss. - hereditary disease. - failed IVF.
  • 51.  It refers to legal process of becoming a non- biological parent,(the child that is not one's biological child).  Many prefer to have their own genetic babies and resort to adoption when all other measures fail.
  • 52. Both had children through IVF (surrogate mothers).